Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270900
Max Phase: Preclinical
Molecular Formula: C36H40ClN9O5S
Molecular Weight: 746.29
Associated Items:
ID: ALA5270900
Max Phase: Preclinical
Molecular Formula: C36H40ClN9O5S
Molecular Weight: 746.29
Associated Items:
Canonical SMILES: Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCNC(=O)COc3ccc(C4CCC(=O)NC4=O)cc3)CC2)n1
Standard InChI: InChI=1S/C36H40ClN9O5S/c1-22-5-3-6-27(37)33(22)44-35(50)28-20-39-36(52-28)42-29-19-30(41-23(2)40-29)46-17-15-45(16-18-46)14-4-13-38-32(48)21-51-25-9-7-24(8-10-25)26-11-12-31(47)43-34(26)49/h3,5-10,19-20,26H,4,11-18,21H2,1-2H3,(H,38,48)(H,44,50)(H,43,47,49)(H,39,40,41,42)
Standard InChI Key: AJNQGWOQPRWRML-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 746.29 | Molecular Weight (Monoisotopic): 745.2562 | AlogP: 4.43 | #Rotatable Bonds: 13 |
Polar Surface Area: 170.78 | Molecular Species: BASE | HBA: 12 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.49 | CX Basic pKa: 8.53 | CX LogP: 4.29 | CX LogD: 4.17 |
Aromatic Rings: 4 | Heavy Atoms: 52 | QED Weighted: 0.11 | Np Likeness Score: -1.75 |
1. Jarusiewicz JA, Yoshimura S, Mayasundari A, Actis M, Aggarwal A, McGowan K, Yang L, Li Y, Fu X, Mishra V, Heath R, Narina S, Pruett-Miller SM, Nishiguchi G, Yang JJ, Rankovic Z.. (2023) Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design., 14 (2.0): [PMID:36793425] [10.1021/acsmedchemlett.2c00436] |
Source(1):